- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (718)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (628)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (64)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (898)
- Research (392)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (604)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (322)
- Symptoms (184)
- Treatment (1776)
Oncologist Joins Media at San Antonio Breast Cancer Symposium
2 minute read | Published December 08, 2011
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on December 08, 2011
Attending the San Antonio Breast Cancer Symposium for the past two years as a member of press is always a very pleasing and rewarding experience. As some of you may know, I'm a semi-professional blogger and very active on Twitter and Facebook.
One thing that I learned from my press activities is that the stereotype of journalists is not necessarily true. There are many talented people, who report accurately, and are often critical about conference presentations. Journalists have an important duty to ensure their messages are correct. I also think that MD Anderson's communication office does a very good job coordinating press activities.
For successful message delivery, coordination is important to make sure the conference presenter and journalist communicate well. Not all journalists have a scientific or medical background, so it's important that conference presentations are accurate, but simple enough for a layperson to understand.
At press conferences, not surprisingly, some academic physicians want to provide many details because they believe that more information makes for an accurate report. But, this is not always true. The accuracy of the content does not always come from the amount of information. If the media does not understand, then the content is pretty much misunderstood. I have seen this many times at press conferences.
Additionally, I find some presenters who don't communicate content well, or are trying to oversell the content. In particular, when primary endpoints of clinical studies are not met and the subset analysis of randomized studies is emphasized, the media can easily tell that the information is an oversell. My advice is to provide relevant data and be passionate about your work, but do not oversell it.
So, what I'm saying from the media perspective is that it's important to be natural, honest and humble as a conference presenter, but assertive when communicating with the press. Gabriel Hortobagyi, M.D., professor and chair of the Department of Breast Medical Oncology, does this well. Of course, he is my boss (disclosure of conflict), but even if you subtract that, he still does very well. It's something that we could all learn from.